|
1
|
Amphlett B, Lawson Z, Abdulrahman GO Jr,
White C, Bailey R, Premawardhana LD and Okosieme OE: Recent trends
in the incidence, geographical distribution, and survival from
thyroid cancer in Wales, 1985–2010. Thyroid. 23:1470–1478. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen AY, Jemal A and Ward EM: Increasing
incidence of differentiated thyroid cancer in the United States,
1988–2005. Cancer. 115:3801–3807. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davies L and Welch HG: Increasing
incidence of thyroid cancer in the United States, 1973–2002. JAMA.
295:2164–2167. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cooper DS, Doherty GM, Haugen BR, Kloos
RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F,
Schlumberger M, et al American Thyroid Association (ATA) Guidelines
Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer:
Revised American Thyroid Association management guidelines for
patients with thyroid nodules and differentiated thyroid cancer.
Thyroid. 19:1167–1214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hay ID, Thompson GB, Grant CS, Bergstralh
EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL,
et al: Papillary thyroid carcinoma managed at the Mayo Clinic
during six decades (1940–1999): Temporal trends in initial therapy
and long-term outcome in 2444 consecutively treated patients. World
J Surg. 26:879–885. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grebe SK and Hay ID: Thyroid cancer nodal
metastases: Biologic significance and therapeutic considerations.
Surg Oncol Clin N Am. 5:43–63. 1996.PubMed/NCBI
|
|
8
|
Angell TE, Lechner MG, Jang JK, Correa AJ,
LoPresti JS and Epstein AL: BRAF V600E in papillary thyroid
carcinoma is associated with increased programmed death ligand 1
expression and suppressive immune cell infiltration. Thyroid.
24:1385–1393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Galon J, Pagès F, Marincola FM, Thurin M,
Trinchieri G, Fox BA, Gajewski TF and Ascierto PA: The immune score
as a new possible approach for the classification of cancer. J
Transl Med. 10:12012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Russell S, Angell T, Lechner M, Liebertz
D, Correa A, Sinha U, Kokot N and Epstein A: Immune cell
infiltration patterns and survival in head and neck squamous cell
carcinoma. Head Neck Oncol. 5:242013.PubMed/NCBI
|
|
11
|
Stewart TJ and Abrams SI: How tumours
escape mass destruction. Oncogene. 27:5894–5903. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McDermott DF: Improving the therapeutic
index of IL-2. Clin Adv Hematol Oncol. 8:862–864. 2010.
|
|
13
|
Shablak A, Sikand K, Shanks JH,
Thistlethwaite F, Spencer-Shaw A and Hawkins RE: High-dose
interleukin-2 can produce a high rate of response and durable
remissions in appropriately selected patients with metastatic renal
cancer. J Immunother. 34:107–112. 2011. View Article : Google Scholar
|
|
14
|
Lechner MG, Russell SM, Bass RS and
Epstein AL: Chemokines, costimulatory molecules and fusion proteins
for the immunotherapy of solid tumors. Immunotherapy. 3:1317–1340.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lechner MG, Karimi SS, Barry-Holson K,
Angell TE, Murphy KA, Church CH, Ohlfest JR, Hu P and Epstein AL:
Immunogenicity of murine solid tumor models as a defining feature
of in vivo behavior and response to immunotherapy. J Immunother.
36:477–489. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liz J and Esteller M: lncRNAs and
microRNAs with a role in cancer development. Biochim Biophys Acta.
1859:169–176. 2016. View Article : Google Scholar
|
|
17
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ørom UA, Derrien T, Beringer M, Gumireddy
K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q,
et al: Long noncoding RNAs with enhancer-like function in human
cells. Cell. 143:46–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y,
Chen N, Sun F and Fan Q: CREB up-regulates long non-coding RNA,
HULC expression through interaction with microRNA-372 in liver
cancer. Nucleic Acids Res. 38:5366–5383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao X, Wang P, Liu J, Zheng J, Liu Y,
Chen J and Xue Y: Gas5 exerts tumor-suppressive functions in human
glioma cells by targeting miR-222. Mol Ther. 23:1899–1911. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Clemson CM, Hutchinson JN, Sara SA,
Ensminger AW, Fox AH, Chess A and Lawrence JB: An architectural
role for a nuclear noncoding RNA: NEAT1 RNA is essential for the
structure of paraspeckles. Mol Cell. 33:717–726. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen LL and Carmichael GG: Altered nuclear
retention of mRNAs containing inverted repeats in human embryonic
stem cells: Functional role of a nuclear noncoding RNA. Mol Cell.
35:467–478. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sasaki YT, Ideue T, Sano M, Mituyama T and
Hirose T: MENepsilon/beta noncoding RNAs are essential for
structural integrity of nuclear paraspeckles. Proc Natl Acad Sci
USA. 106:2525–2530. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sunwoo H, Dinger ME, Wilusz JE, Amaral PP,
Mattick JS and Spector DL: MEN epsilon/beta nuclear-retained
non-coding RNAs are up-regulated upon muscle differentiation and
are essential components of paraspeckles. Genome Res. 19:347–359.
2009. View Article : Google Scholar :
|
|
28
|
Zeng C, Xu Y, Xu L, Yu X, Cheng J, Yang L,
Chen S and Li Y: Inhibition of long non-coding RNA NEAT1 impairs
myeloid differentiation in acute promyelocytic leukemia cells. BMC
Cancer. 14:6932014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chakravarty D, Sboner A, Nair SS,
Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K,
Kossai M, et al: The oestrogen receptor alpha-regulated lncRNA
NEAT1 is a critical modulator of prostate cancer. Nat Commun.
5:5383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Choudhry H, Albukhari A, Morotti M, Haider
S, Moralli D, Smythies J, Schödel J, Green CM, Camps C, Buffa F, et
al: Tumor hypoxia induces nuclear paraspeckle formation through
HIF-2α dependent transcriptional activation of NEAT1 leading to
cancer cell survival. Oncogene. 34:45462015. View Article : Google Scholar
|
|
31
|
Guo S, Chen W, Luo Y, Ren F, Zhong T, Rong
M, Dang Y, Feng Z and Chen G: Clinical implication of long
non-coding RNA NEAT1 expression in hepatocellular carcinoma
patients. Int J Clin Exp Pathol. 8:5395–5402. 2015.PubMed/NCBI
|
|
32
|
Kim YS, Hwan JD, Bae S, Bae DH and Shick
WA: Identification of differentially expressed genes using an
annealing control primer system in stage III serous ovarian
carcinoma. BMC Cancer. 10:5762010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li Z, Liu YH, Diao HY, Ma J and Yao YL:
Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating
miR-449b-5p/c-Met axis. Tumour Biol. 37:673–683. 2016. View Article : Google Scholar
|
|
34
|
Frixa T, Donzelli S and Blandino G:
Oncogenic MicroRNAs: key players in malignant transformation.
Cancers (Basel). 7:2466–2485. 2015. View Article : Google Scholar
|
|
35
|
Huntzinger E and Izaurralde E: Gene
silencing by microRNAs: Contributions of translational repression
and mRNA decay. Nat Rev Genet. 12:99–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang P, Liu YH, Yao YL, Li Z, Li ZQ, Ma J
and Xue YX: Long non-coding RNA CASC2 suppresses malignancy in
human gliomas by miR-21. Cell Signal. 27:275–282. 2015. View Article : Google Scholar
|
|
37
|
Mardente S, Mari E, Massimi I, Fico F,
Faggioni A, Pulcinelli F, Antonaci A and Zicari A: HMGB1-induced
cross talk between PTEN and miRs 221/222 in thyroid cancer. Biomed
Res Int. 2015:5120272015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang Z, Chen S, Luan X, Li Y, Liu M, Li X,
Liu T and Tang H: MicroRNA-214 is aberrantly expressed in cervical
cancers and inhibits the growth of HeLa cells. IUBMB Life.
61:1075–1082. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang F, Liu M, Li X and Tang H: MiR-214
reduces cell survival and enhances cisplatin-induced cytotoxicity
via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett.
587:488–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wen Z, Lei Z, Ma JA, Li XZ, Zheng XN and
Deng XW: The inhibitory role of miR-214 in cervical cancer cells
through directly targeting mitochondrial transcription factor A
(TFAM). Eur J Gynaecol Oncol. 35:676–682. 2014.
|
|
41
|
Chen DL, Wang ZQ, Zeng ZL, Wu WJ, Zhang
DS, Luo HY, Wang F, Qiu MZ, Wang DS, Ren C, et al: Identification
of MicroRNA-214 as a negative regulator of colorectal cancer liver
metastasis by way of regulation of fibroblast growth factor
receptor 1 expression. Hepatology. 60:598–609. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Long LM, He BF, Huang GQ, Guo YH, Liu YS
and Huo JR: microRNA-214 functions as a tumor suppressor in human
colon cancer via the suppression of ADP-ribosylation factor-like
protein 2. Oncol Lett. 9:645–650. 2015.PubMed/NCBI
|
|
43
|
Penna E, Orso F, Cimino D, Vercellino I,
Grassi E, Quaglino E, Turco E and Taverna D: miR-214 coordinates
melanoma progression by upregulating ALCAM through TFAP2 and
miR-148b downmodulation. Cancer Res. 73:4098–4111. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: MiR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang H, Kong W, He L, Zhao JJ, O'Donnell
JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV and Cheng JQ:
MicroRNA expression profiling in human ovarian cancer: miR-214
induces cell survival and cisplatin resistance by targeting PTEN.
Cancer Res. 68:425–433. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gong W, Zheng J, Liu X, Ma J, Liu Y and
Xue Y: Knockdown of NEAT1 restrained the malignant progression of
glioma stem cells by activating microRNA let-7e. Oncotarget. Aug
19–2016.Epub ahead of print. View Article : Google Scholar
|
|
47
|
Geisler S, Lojek L, Khalil AM, Baker KE
and Coller J: Decapping of long noncoding RNAs regulates inducible
genes. Mol Cell. 45:279–291. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Barnhill LM, Williams RT, Cohen O, Kim Y,
Batova A, Mielke JA, Messer K, Pu M, Bao L, Yu AL, et al: High
expression of CAI2, a 9p21-embedded long noncoding RNA, contributes
to advanced-stage neuroblastoma. Cancer Res. 74:3753–3763. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nie FQ, Zhu Q, Xu TP, Zou YF, Xie M, Sun
M, Xia R and Lu KH: Long non-coding RNA MVIH indicates a poor
prognosis for non-small cell lung cancer and promotes cell
proliferation and invasion. Tumour Biol. 35:7587–7594. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang F, Huo XS, Yuan SX, Zhang L, Zhou WP,
Wang F and Sun SH: Repression of the long noncoding RNA-LET by
histone deacetylase 3 contributes to hypoxia-mediated metastasis.
Mol Cell. 49:1083–1096. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sun C, Li S, Zhang F, Xi Y, Wang L, Bi Y
and Li D: Long non-coding RNA NEAT1 promotes non-small cell lung
cancer progression through regulation of miR-377-3p-E2F3 pathway.
Oncotarget. Jun 16–2016.Epub ahead of print.
|
|
53
|
Naganuma T and Hirose T: Paraspeckle
formation during the biogenesis of long non-coding RNAs. RNA Biol.
10:456–461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Tani H, Torimura M and Akimitsu N: The RNA
degradation pathway regulates the function of GAS5 a non-coding RNA
in mammalian cells. PLoS One. 8:e556842013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY,
Gong W and Quan ZW: Long non-coding RNA CCAT1 promotes gallbladder
cancer development via negative modulation of miRNA-218-5p. Cell
Death Dis. 6:e1583. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Xiong X, Ren HZ, Li MH, Mei JH, Wen JF and
Zheng CL: Down-regulated miRNA-214 induces a cell cycle G1 arrest
in gastric cancer cells by up-regulating the PTEN protein. Pathol
Oncol Res. 17:931–937. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Qiang R, Wang F, Shi LY, Liu M, Chen S,
Wan HY, Li YX, Li X, Gao SY and Sun BC: Plexin-B1 is a target of
miR-214 in cervical cancer and promotes the growth and invasion of
HeLa cells. Int J Biochem Cell Biol. 43:632–641. 2011. View Article : Google Scholar : PubMed/NCBI
|
